COVID-19 vaccine: Moderna to begin final human trial at end of July – NBC News

Share this article!

The Cambridge, Massachusetts-based biotech business is the very first to reveal an estimated start date for stage 3 trials in the United States.Full coverage of the coronavirus outbreak Information about the trial, including guidance for vaccine volunteers, was posted on on Tuesday.Let our news satisfy your inbox. The company intends to register 30,000 adults in the clinical trial, which is developed to test whether the vaccine works to prevent COVID-19. The trial will likewise look at the vaccines safety.Participants will either get a placebo or the vaccine.